Details for New Drug Application (NDA): 022013
✉ Email this page to a colleague
The generic ingredient in OLUX E is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 022013
Tradename: | OLUX E |
Applicant: | Mylan |
Ingredient: | clobetasol propionate |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 022013
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Jan 12, 2007 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 5, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 31, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES |
Expired US Patents for NDA 022013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription